Media

Cardlytics

Cardlytics released FY2025 9 Months earnings on November 5 After-Market EST, actual revenue USD 177.18 M, actual EPS USD -1.7945

Cardlytics released FY2025 Q3 earnings on November 5 After-Market EST, actual revenue USD 52.03 M (forecast USD 54.54 M), actual EPS USD -1.3585 (forecast USD -0.3266)

Cardlytics to Release FY2025 Q3 Earnings on November 5 After-Market EST, Forecast Revenue USD 54.54 M, EPS USD -0.3266

Cardlytics Launches Major Layoffs to Cut Costs

Cardlytics released FY2025 Semi-Annual earnings on August 6 After-Market (EST), actual revenue USD 125.15M, actual EPS USD -0.4313

Cardlytics released FY2025 Q2 earnings on August 6 After-Market (EST), actual revenue USD 63.25M (forecast USD 64.02M), actual EPS USD -0.1759 (forecast USD -0.39)

Cardlytics to Release FY2025 Q2 Earnings on August 6 After-Market EST, Forecast Revenue USD 64.02 M, EPS USD -0.39

Cardlytics Inc. Launches New Customer Insights Dashboards

Cardlytics extends and modifies agreement with JPMorgan

Cardlytics Inc. CLO reports common stock disposition

Cardlytics Holds Annual Shareholders Meeting and Approves Multiple Proposals

Cardlytics Inc. Launches Customer Loyalty Rewards Platform

Cardlytics CFO Disposes of Common Stock

Cardlytics released FY2025 Q1 earnings on May 7 After-Market EST, actual revenue USD 61.9 M (forecast USD 58.01 M), actual EPS USD -0.26 (forecast USD -0.48)

Cardlytics Inc reports Q1 loss of 23 cents per share

Cardlytics to release FY2025 Q1 earnings on May 7 After-Market EST, forecast revenue USD 58.01 M, EPS USD -0.48

Cardlytics Inc. to Release Q1 2025 Earnings

Cardlytics released FY2024 annual earnings on March 12 After-Market (EST), actual revenue 278.3 M USD (forecast 267.93 M USD), actual EPS -3.9143 USD (forecast -4.058 USD)

Cardlytics released FY2024 Q4 earnings on March 12 After-Market (EST), actual revenue $74M (forecast $63.63M), actual EPS -$0.3056 (forecast -$0.4475)

Cardlytics reports fourth-quarter net income of -$15.59 million, below IBES expectations

Processa Pharmaceuticals

cbdMD

VYNE Therapeutics

Inspirato

Agape ATP

Aditxt

Irobot

Udemy

DBV Tech

NOODLES

Etoiles Capital

Eva Live, Inc.

福克斯-A

福克斯-B

Trade Desk

紐約時報

DoubleVerify

Integral Ad Science

Criteo SA

MNTN

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap